[Ip-health] ITPC Activists Occupy Novartis: Demand Access to Medicine Over Corporate Profit

Andrew Hunter apnswbkk at gmail.com
Thu Feb 23 00:57:10 PST 2012


Fantastic, we need more and more of this!

And maybe for next board meeting it's time to #occupytheglobalfund

Until WE get OUR fund back....

Andrew Hunter

On Thursday, February 23, 2012, shiba phurailatpam wrote:

> **
>
>
> Brilliant!!!!
> On Feb 23, 2012, at 2:24 AM, Gregg Gonsalves wrote:
>
> This is amazing!!!!
> G
>
> On Wed, Feb 22, 2012 at 2:11 PM, Matthew Kavanagh <matthew at healthgap.org>wrote:
>
> **
>
>
> Wednesday, 22 February 2012
>
> *For Immediate Release*
>
> *Activists Occupy Novartis: Demand Access to Medicine Over Corporate
> Profit** *
>
> *In NY, DC, and Boston, activists take over Novartis offices warning that
> pharma giant Novartis’ lawsuit in India could deny millions around the
> world to lifesaving medicines.*
>
> *Contact: *Matthew Kavanagh, Health GAP, 202-486-2488,
> matthew at healthgap.org; Darshali Vyas, Student Global AIDS Campaign,
> 859-420-6498, davyas at college.harvard.edu
> AIDS activists, students, and community groups “OCCUPIED” the offices of
> pharma giant Novartis today in three U.S. cities on the eve of the Swiss
> pharmaceutical company’s annual shareholders meeting in Switzerland.  The
> effort was part of a global day of action drawing attention to the
> company’s lawsuit against cancer patients and the government of India,
> aiming to reinterpret India’s patent standards to block access to
> life-saving generic medicines.
>
> In 2006, Novartis sued the Indian government after its request for a
> patent on its blockbuster cancer drug Gleevec was denied. The Novartis
> version of the drug costs roughly ten times the cost of the high-quality
> generics on the market and the company is trying to stop production of
> those versions.  Prior to 2005, India did not grant patents on medicines
> at all – a policy that fostered generic production of essential medicines
> then shipped to poor countries around the world. After a World Trade
> Organization agreement forced India to start granting patents in 2005,
> India created Section 3(d) of its patent law that requires pharmaceutical
> companies to demonstrate that changes to an existing substance actually
> shows increased efficacy for patients before a new patent is
> granted—preventing frivolous patents. Novartis was unable to show that its
> tweaks to the basic compound in Gleevec had resulted in improved efficacy
> in treating cancer.
>
> “Without this protective provision in place, patents will be granted
> indiscriminately on trivial changes to existing medicines, thereby
> preventing generic production and allowing drug companies to charge high
> prices,” explained Brook Baker, policy analyst for Health GAP (Global
> Access Project).
>
> India has historically proved vital in the global fight against
> AIDS—producing the vast majority of high quality, affordable drugs used in
> Africa and throughout the world.
>
> “Novartis’s shortsighted corporate greed could have disastrous long-term
> consequences for nations reliant on generic medicines. India supplies 80%
> of AIDS medicines in the developing world as well as good quality generic
> equivalents for many other health needs.  Poor patients will continue to
> need access to new, improved, and affordable medicines instead of having
> them blocked by successive patent monopolies,” said Darshali Vyas, from
> Harvard College and member of the Student Global AIDS Campaign.
>
> Since Novartis initiated action against the Indian government, protests
> have been held around the world. On Wednesday, demonstrators in New York,
> Washington, and Boston stood in solidarity with actions in India,
> Switzerland, and other regions. “We’re here to try to ensure that India
> remains the pharmacy of the developing world,” said Katrina Ciraldo, Boston
> University medical student and member of Occupy Boston’s Health Jus
>
> _______________________________________
> https://lists.critpath.org/mailman/listinfo/healthgap
> HealthGAP is a public list. To post, send to healthgap at critpath.org<javascript:_e({}, 'cvml', 'healthgap at critpath.org');>.
> To subscribe, unsubscribe, or for help with your account, send an email to
> info at healthgap.org <javascript:_e({}, 'cvml', 'info at healthgap.org');>
>
> www.healthgap.org
>
>
>  __._,_.___
>   Reply to sender <javascript:_e({}, 'cvml',
> 'shiba.p at gmail.com?subject\x3dRe%3A%20%5BHEALTHGAP%5D%20ITPC%20Activists%20Occupy%20Novartis%3A%20Demand%20Access%20to%20Medicine%20Over%20Corporate%20Profit');>| Reply
> to group <javascript:_e({}, 'cvml',
> 'internationaltreatmentpreparedness at yahoogroups.com?subject\x3dRe%3A%20%5BHEALTHGAP%5D%20ITPC%20Activists%20Occupy%20Novartis%3A%20Demand%20Access%20to%20Medicine%20Over%20Corporate%20Profit');>| Reply
> via web post<http://groups.yahoo.com/group/internationaltreatmentpreparedness/post;_ylc=X3oDMTJxaWc5b3VsBF9TAzk3MzU5NzE0BGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBG1zZ0lkAzIxODUyBHNlYwNmdHIEc2xrA3JwbHkEc3RpbWUDMTMyOTk2ODA2MA--?act=reply&messageNum=21852>| Start
> a New Topic<http://groups.yahoo.com/group/internationaltreatmentpreparedness/post;_ylc=X3oDMTJlMGliMGkzBF9TAzk3MzU5NzE0BGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBHNlYwNmdHIEc2xrA250cGMEc3RpbWUDMTMyOTk2ODA2MA-->
> Messages in this topic<http://groups.yahoo.com/group/internationaltreatmentpreparedness/message/21852;_ylc=X3oDMTM2cG1hNGdxBF9TAzk3MzU5NzE0BGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBG1zZ0lkAzIxODUyBHNlYwNmdHIEc2xrA3Z0cGMEc3RpbWUDMTMyOTk2ODA2MAR0cGNJZAMyMTg1Mg-->(
> 1)
>  Recent Activity:
>
>    - New Members<http://groups.yahoo.com/group/internationaltreatmentpreparedness/members;_ylc=X3oDMTJmNnFxZ2xyBF9TAzk3MzU5NzE0BGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBHNlYwN2dGwEc2xrA3ZtYnJzBHN0aW1lAzEzMjk5NjgwNjA-?o=6>
>    1
>
>  Visit Your Group<http://groups.yahoo.com/group/internationaltreatmentpreparedness;_ylc=X3oDMTJlc3B1djRlBF9TAzk3MzU5NzE0BGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBHNlYwN2dGwEc2xrA3ZnaHAEc3RpbWUDMTMyOTk2ODA2MA-->
>  [image: Yahoo! Groups]<http://groups.yahoo.com/;_ylc=X3oDMTJkMmRiNHRtBF9TAzk3NDc2NTkwBGdycElkAzk3MjcyMjEEZ3Jwc3BJZAMxNzA1MDYxNTkwBHNlYwNmdHIEc2xrA2dmcARzdGltZQMxMzI5OTY4MDYw>
> Switch to: Text-Only <javascript:_e({}, 'cvml',
> 'internationaltreatmentpreparedness-traditional at yahoogroups.com?subject\x3dChange+Delivery+Format:+Traditional');>,
> Daily Digest <javascript:_e({}, 'cvml',
> 'internationaltreatmentpreparedness-digest at yahoogroups.com?subject\x3dEmail+Delivery:+Digest');>•
> Unsubscribe <javascript:_e({}, 'cvml',
> 'internationaltreatmentpreparedness-unsubscribe at yahoogroups.com?subject\x3dUnsubscribe');>• Terms
> of Use <http://docs.yahoo.com/info/terms/>
>    .
>
> __,_._,___
>


-- 
Andrew Hunter
sexwork.asia



More information about the Ip-health mailing list